These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 30026411)

  • 1. [Analysis of Fecal Cancer-Specific DNA to Detect Colorectal Neoplasia].
    Nagasaka T; Yamaguchi Y
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):906-910. PubMed ID: 30026411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].
    Quintero E
    Gastroenterol Hepatol; 2009 Oct; 32(8):565-76. PubMed ID: 19577340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Robertson DJ; Lee JK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Lieberman D; Levin TR; Rex DK
    Am J Gastroenterol; 2017 Jan; 112(1):37-53. PubMed ID: 27753435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fecal Biomarker for Colorectal Cancer Diagnosis].
    Koga Y; Yamazaki N; Matsumura Y
    Rinsho Byori; 2015 Mar; 63(3):361-8. PubMed ID: 26524859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is fecal occult blood testing more sensitive for left- versus right-sided colorectal neoplasia? A systematic literature review.
    Haug U; Knudsen AB; Brenner H; Kuntz KM
    Expert Rev Mol Diagn; 2011 Jul; 11(6):605-16. PubMed ID: 21745014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression analysis using a highly sensitive DNA microarray for colorectal cancer screening.
    Koga Y; Yamazaki N; Takizawa S; Kawauchi J; Nomura O; Yamamoto S; Saito N; Kakugawa Y; Otake Y; Matsumoto M; Matsumura Y
    Anticancer Res; 2014 Jan; 34(1):169-76. PubMed ID: 24403458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient perceptions of stool-based DNA testing for colorectal cancer screening.
    Schroy PC; Heeren TC
    Am J Prev Med; 2005 Feb; 28(2):208-14. PubMed ID: 15710277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal DNA for noninvasive diagnosis of colorectal cancer in immunochemical fecal occult blood test-positive individuals.
    Calistri D; Rengucci C; Casadei Gardini A; Frassineti GL; Scarpi E; Zoli W; Falcini F; Silvestrini R; Amadori D
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2647-54. PubMed ID: 20929882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of faecal markers in screening for colorectal neoplasia: a European group on tumor markers position paper.
    Duffy MJ; van Rossum LG; van Turenhout ST; Malminiemi O; Sturgeon C; Lamerz R; Nicolini A; Haglund C; Holubec L; Fraser CG; Halloran SP
    Int J Cancer; 2011 Jan; 128(1):3-11. PubMed ID: 20824704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower risk of advanced neoplasia among patients with a previous negative result from a fecal test for colorectal cancer.
    Denters MJ; Deutekom M; Bossuyt PM; Stroobants AK; Fockens P; Dekker E
    Gastroenterology; 2012 Mar; 142(3):497-504. PubMed ID: 22108194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal DNA biomarkers for the detection of colorectal neoplasia: attractive, but is it feasible?
    Brenner DE; Rennert G
    J Natl Cancer Inst; 2005 Aug; 97(15):1107-9. PubMed ID: 16077063
    [No Abstract]   [Full Text] [Related]  

  • 12. Faecal occult blood testing for colorectal cancer screening: the past or the future.
    Benton SC; Seaman HE; Halloran SP
    Curr Gastroenterol Rep; 2015 Feb; 17(2):428. PubMed ID: 25673567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colon cancer screening strategies.
    Agrawal J; Syngal S
    Curr Opin Gastroenterol; 2005 Jan; 21(1):59-63. PubMed ID: 15687886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early detection of colorectal cancer with faecal occult blood test screening.
    Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
    Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer.
    Robertson DJ; Lee JK; Boland CR; Dominitz JA; Giardiello FM; Johnson DA; Kaltenbach T; Lieberman D; Levin TR; Rex DK
    Gastroenterology; 2017 Apr; 152(5):1217-1237.e3. PubMed ID: 27769517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is fecal DNA testing superior to fecal occult-blood testing for colorectal cancer screening?
    Capellá G
    Nat Clin Pract Oncol; 2005 May; 2(5):234-5. PubMed ID: 16264954
    [No Abstract]   [Full Text] [Related]  

  • 17. Fecal occult blood testing.
    Sanford KW; McPherson RA
    Clin Lab Med; 2009 Sep; 29(3):523-41. PubMed ID: 19840685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fecal methylated DNA for the detection of colorectal cancer].
    von Delius S; Jung A; Schmid RM
    Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia.
    Smith A; Young GP; Cole SR; Bampton P
    Cancer; 2006 Nov; 107(9):2152-9. PubMed ID: 16998938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene methylation in stool for the screening of colorectal cancer and pre-malignant lesions].
    Kang YP; Cao FA; Chang WJ; Lou Z; Wang H; Wu LL; Fu CG; Cao GW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Jan; 14(1):52-6. PubMed ID: 21271382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.